| 1. Diagnosis and treatment of the accessory breast tumors |
Page:— |
| 2. The rectal administration of morphine sulphate controlled release tablets in the treatment of cancer pain |
Page:— |
| 3. Effect of HELICOBACTER PYLORI infection on apoptosis and proliferation along with P53 gene expression in gastric epithelium |
Page:— |
| 4. Analysis of treatment and prognosis of vulvar cancer in 51 cases |
Page:— |
| 5. Continuous low dose vinorelbin with cisplatin in the treatment of advanced non-small-cell lung cancer |
Page:— |
| 6. Advances in the research on correlation between homeobox genes and tumors |
Page:— |
| 7. Research advances of National Surgical Adjuvant Breast and Bowel Project breast cancer trials |
Page:— |
| 8. Adjuvant treatment of 126 cases of stage Ⅰb、Ⅱa cervical carcinoma after radical hysterectomy and pelvic lymphadenectomy |
Page:— |
| 9. The study of combined treatment for advanced endometrium carcinoma──A report of 45 cases |
Page:— |
| 10. Pulmonary inflammatory pseudotumor:clinical characteristics and surgical treatment |
Page:— |
| 11. Gemcitabine in the treatment of 8 cases with advanced liver cancer |
Page:— |
| 12. 36 cases of advanced NSCLC by combined chemotherapy based on gemcitabine |
Page:— |
| 13. Single-agent vinorelbine in the treatment of elderly patients with advanced non-small-cell lung cancer |
Page:— |
| 14. Application of rhG-CSF in patients with plasma cell disease treated with autologus peripheral blood stem cell transplantation |
Page:— |
| 15. Treatment of advanced pancreatic cance with gemcitabine,5-FU and cisplatine |
Page:— |
| 16. Metabolism and efficacy study of ~(125)I-anti-AFP administrated by interventional route for primary liver cancer |
Page:— |
| 17. Tumor morkers in the diagnosis of malignant lung tumors |
Page:— |
| 18. Biological response modifiers combined with radiotherapy and chemotherapy for stage Ⅲ non-small-cell lung cancer |
Page:— |
| 19. Clinical effect and side reactions of elderly patients with advanced NSCLC by gemcitabine with cisplatin |
Page:— |
| 20. Influnce of doxoricin cytotoxicity by lipid peroxidation of docosahexaenic acids |
Page:— |
| 21. Effects of p53 overexpression on the balance of helper T cell 1 with helper T cell 2 in colorectal tumors |
Page:— |
| 22. Clinical significance and hematologic features of CD56~+ acute myeloid leukemia |
Page:— |
| 23. Expression of VEGF and bFGF in xenografts of human osteosarcoma OS-732 on chick embryo chorioallantoic membrane and its significance |
Page:— |
| 24. The construction of eukaryotic expressive vector of RI gene and the effects of the transfected pLNCX-ri on the growth of C6 glioma cells |
Page:— |
| 25. The relationship of platelet phospholipase A, and tumor |
Page:— |
| 26. Postoperative radiation therapy in gastric cancer |
Page:— |
| 27. Prognostic factors of early stage non-small cell lung cancer |
Page:— |
| 28. Clinical and pathological analysis of primary malignant lymphoma of the breast |
Page:— |
| 29. The value of ~(99m)Tc-MIBI imaging in differentiating of breast masses |
Page:— |
| 30. Clinical analysis of radiotherapy plus drug intra-cavitary infusion for 184 patients on carcinoma of the bladder after operation |
Page:— |
| 31. Assessment on the efficacy of intraperitoneal chemotherapy on progressive gastric cancer after radical treatment |
Page:— |
| 32. Clinical observation of oxaliplatin combination with 5-fluorouracil/folinic acid therapy in advanced colorectal cancer |
Page:— |
| 33. Evaluation of jejunal interposition reconstruction P and SS type after total gastrectomy in patients with gastric carcinoma : reports of 31 cases |
Page:— |
| 34. Paclitaxel combined with chemotherapy in the treatment of advanced breast cancer |
Page:— |
| 35. The clinical value of mammary sentinel lymphoscintigraphy in breast cancer |
Page:— |
| 36. Clinical analysis of the combined chemotherapy with navelbine concurrent with palliative radiotherapy on stage M, nasopharyngeal carcinoma |
Page:— |
| 37. Preliminary study of intensity modulation radiation therapy for patients with prostate carcinoma |
Page:— |
| 38. On the clinicopathology, ultrastructure and immunohistochemistry study of intracranial microcystic meningioma |
Page:— |
| 39. Expression of CD117 in gastrointestinal stromal tumors and their significance |
Page:— |
| 40. Experimented gene therapy for prostate cancer with HSV-TK/GCV system |
Page:— |
| 41. Vascular endothelial growth factor expression in non-small cell lung cancer and their clinical relation |
Page:— |
| 42. Loss of Fhit expression and significance in non - small cell lung cancer |
Page:— |
| 43. Detection of chromosome 8 abnormalities in carcinoma of endometrium (endometrial carcinoma of uterus) by fluorescence in situ hybridization( FISH) |
Page:— |
| 44. The relationship between the expression of ET, the content of DNA and prognosis in lung cancer |
Page:— |
| 45. Preserving fertility treatment for 40 patients with ovarian malignant tumors |
Page:— |
| 46. Microcystins in drinking water and cancer mortality in a city along Taihu Lake |
Page:— |
| 47. Consistency and controversy of surgical treatment on locally advanced NSCLC |
Page:— |
| 48. Research advances in drug transporters and multidrug resistance |
Page:— |
| 49. Clinical features and management of mucosa-associated lymphoid tissue lymphoma |
Page:— |
| 50. Advances in research on relationship between mitochondrial genome and tumor |
Page:— |
| 51. Gemcitabine plus cisplatin for the treatment of anthracycine-resistant advanced breast cancer |
Page:— |
| 52. Values of resecting the lymph nodes adjacent to the recurrent laryngeal nerve in the operation on cNo thyroid papillary carcinoma |
Page:— |
| 53. Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy and prognosis |
Page:— |
| 54. Phase Ⅱ clinical trial on docetaxel in the treatment of non-small-cell lung cancer |
Page:— |
| 55. Prognostic factors in 83 patients with cervical carcinoma treated with high-dose-rate brachytherapy and external radiotherapy |
Page:— |
| 56. Chemotherapy adjunctive to definitive radiotherapy in locally advanced nasopharyngeal carcinoma (NPC):prospective randomized study |
Page:— |
| 57. Three-dimensional conformal radiotherapy (3DCRT) in treating patients with recurrent nasopharyngeal carcinoma:planning optimization and dosimetry analysis |
Page:— |
| 58. Diagnosis and therapy of 26 cases with primary malignant cervical lymphoma |
Page:— |
| 59. Primary nasal type extranodal NK/T cell lymphoma of adrenal gland:clinical and pathological characters and immunophenotype |
Page:— |
| 60. 3DRT for 35 patients with malignancy biliary obstruction |
Page:— |
| 61. Blue sentinel lymph node detection in patients with cervical cancer |
Page:— |
| 62. Evaluation of recurrent gastric malignancy with computed tomography |
Page:— |
| 63. The prognosis of patients with stage Ⅰb-Ⅱb node-negative cervical carcinoma |
Page:— |
| 64. Effect of IFN-? on the growth of human cervical cancer transplanted subcutaneously in nude mice |
Page:— |
| 65. Effect of retroviral vectors carried sense or antisense TGF?1 on human bladder cancer cells in vitro |
Page:— |
| 66. Reversal effect on ADM resistance in human leukaemia cell subline resistant to ADM(K562/ADM) of anti-FasL |
Page:— |
| 67. Expression of cyclooxygenase-2,vascular endothelial growth factor and their prognostic significance in gastric carcinoma |
Page:— |
| 68. Influence of wild-type p53 gene tranfection on telomerase activity in human HCC-9204 cell |
Page:— |
| 69. Expression of MEK-1 in regulation of ?V integrin and E-cadherin of MCF-7 breast cancer cells |
Page:— |
| 70. Preliminary application of the sentinel lymph node detection in early cervical cancer |
Page:— |
| 71. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in cervical carcinomas and its significance |
Page:— |
| 72. Expression of metastasis suppressor gene Kai1 in ovarian epithelial tumor and its significance |
Page:— |
| 73. Survivin ,P21~(WAF1/CIP1),Cyclin D1 proteins expression in cervical carcinoma:correlations with recurrence of early stage cervical cancer of the uterus |
Page:— |
| 74. Advances in research of CD30~+ anaplastic large cell lymphoma |
Page:— |
| 75. Progress of the relationship between cyclooxygenase-2 and breast cancer |
Page:— |
| 76. Advances in diagnosis and management of malignant pleural mesothelioma |
Page:— |
| 77. Capecitabine in the treatment of relapsed breast cancer |
Page:— |
| 78. Relationship of chemosensitivity on cancer in vitro and the clinical experience |
Page:— |
| 79. Radiofrequency chemohyperthermia combined with intravenous chemotheray for malig nant ascites |
Page:— |
| 80. Combination chemotherapy with navelbine(NVB) and epirubicin( e-ADM )in treating metastatic breast cancer |
Page:— |
| 81. Salvage treatment of primary recurrence in patients with laryngeal cancer after definitive radiotherapy |
Page:— |
| 82. Neoadjuvant chemotherapy and preoperative radiation for stage Ⅰb-Ⅱb cervical cancer |
Page:— |
| 83. Radiotherapeutic management of regional lymph nodes recurrence following mastectomy |
Page:— |
| 84. Preliminary results of radiotherapy plus ultrasound hyperthermia for malignant tumors |
Page:— |
| 85. Efficacy of capecitabine combined with intrahepatic transcatheter arterial chemo embolization in primary hepatic carcinoma |
Page:— |
| 86. Gemcitabine plus cisplatin vs gemcitabine plus carboplatin in patients with adva nced non-small-cell lung cancer |
Page:— |
| 87. Effect of amifostine on efficacy and hematologic toxicity in patients with advan ced non-small-cell lung cancer treated with chemotherapy |
Page:— |
| 88. Three-dimensional conformal radiotherapy(3-DCRT)combined with radiofrequency hyperthermia for locally advanced non-small-cell lung cancer(LANSCLC) |
Page:— |
| 89. Combinations of neoadjuvant chemoradiotherapy and transurethral resection for bladder cancer with muscle invasion |
Page:— |
| 90. Analysis of dose-volume dependence of acute esophagitis using a random-effect model for concurrent chemoradiation therapy for non-small-cell lung cancer (NS CLC) |
Page:— |
| 91. Clinical benefit of gemcitabine plus cisplatin 3-week regimen for patients with advanced non-small-cell lung cancer (NSCLC): a prospective observational study |
Page:— |
| 92. Expression and clinical significance of MDR_1 / P-gp,C-erbB-2 in breast cancer |
Page:— |
| 93. Role of Bcl-2 Phosphorylation in mediating paclitaxel induced-apoptosis in hum an retinoblastoma Y79 cells |
Page:— |
| 94. Prognostic effect of cyclooxygenase-2 in non-small-cell lung cancer |
Page:— |
| 95. Gene diagnosis and clinical significance of micrometastases in lymph nodes, peri pheral blood and bone marrow in non-small-cell lung cancer patients |
Page:— |
| 96. Research progress on the mechanism of invasion and metastasis of colorectal carcinoma |
Page:— |
| 97. Problems of target defined in nasopharyngeal carcinoma |
Page:— |
| 98. Advances in research on CLN3 gene and diseases |
Page:— |
| 99. Advances in research on the diagnosis and therapy of lung cancer with bone metastases |
Page:— |
| 100. Single agent vinorelbine for the treatment of advanced non-small-cell lung cancer in 27 elderly patients |
Page:— |
| 101. Comparison between urinary cytokeratin test and voided urine cytology for detection of bladder cancer |
Page:— |
| 102. Multidisciplinary treatment of epithelial ovarian carcinoma in stage Ⅲ and prognostic analysis |
Page:— |
| 103. p16 gene methylation status of and its effect on mRNA expression in hepatocellular carcinoma |
Page:— |
| 104. Clinical significance of combined measuring CYFRA21-1,CA153 and NSE for lung cancer |
Page:— |
| 105. Intraperitoneal chemotherapy combined with intravenous chemotherapy after operation in the ovarian epithelial cancer |
Page:— |
| 106. Influence of dose distribution selected from different beam orientation for a nasopharyngeal carcinoma IMRT plan |
Page:— |
| 107. Sequential chemotherapy and conventional radiotherapy in treatment of 45 cases of brain metastases of lung cancer |
Page:— |
| 108. Otolaryngeal mucoepidermoid carcinoma:a clinicopathological study of 15 cases |
Page:— |
| 109. Canstatin high level expression system and its biology effects on lung cancer |
Page:— |
| 110. Correlation between Akt phosphorylation and loss of PTEN protein expression in non-small-cell lung cancer |
Page:— |
| 111. Three-dimensional conformal radiotherapy for brain gliomas |
Page:— |
| 112. Effect of hydroxycamptothecin with thermotherapy on angiogenesis in vivo and in vitro |
Page:— |
| 113. DNA polymerase ? gene mutation in gastric carcinoma and the relationship with H.pylori infection |
Page:— |
| 114. Inhibitory effects of shRNA targeting CD44v3 on invasion behavior of human colon cancer cell SW480 in vitro induced by hyaluronan |
Page:— |
| 115. Clinical biology value of p53 overexpression in Chinese breast cancer by Meta analysis |
Page:— |
| 116. Apoptosis of lung adenocarcinoma SPC-A1 cells induced by Livin isoform-specific gene silencing |
Page:— |
| 117. Advances in clinical investigation of adjuvant radiotherapy in rectal cancer |
Page:— |
| 118. A clinical study in undifferentiated small cell carcinoma of the esophagus |
Page:— |
| 119. The value of magnetic resonance imaging(MRI) staging in radiotherapy of early prostate carcinoma |
Page:— |
| 120. Radiotherapy in the patients with bladder carcinoma treated by conservative surgery |
Page:— |
| 121. Transcatheter arterial chemoembolization combined with 3-dimensional conformal radiotherapy for primary hepatic carcinoma |
Page:— |
| 122. The definition and delineation of lymph nodes regions of lung cancer on CT transections |
Page:— |
| 123. Progress of clinical brachytherapy application |
Page:— |
| 124. Clinical application criteria and progress in ?(X) stereotatic radiotherapy |
Page:— |
| 125. Advances in clinical application of CT in the image-guided radiotherapy |
Page:— |
| 126. Functional imaging and biological target volume:advances of experimental and clinical research |
Page:— |
| 127. Progress in the treatment of loco-regionally advanced nasopharyngeal carcinoma |
Page:— |
| 128. Treatment progression of early nasopharyngeal carcinoma |
Page:— |
| 129. Current status of radiotherapy for non-Hodgkin's lymphoma |
Page:— |
| 130. Progression of treatment in locally advanced breast cancer |
Page:— |
| 131. Concurrent chemoradiotherapy in cancer treatment |
Page:— |
| 132. New developments in gastrointestinal stromal tumor |
Page:— |
| 133. Nedaplatin combined with radiotherapy in the treatment of advanced nasopharyngeal carcinoma |
Page:— |
| 134. A randomized clinical study of capecitabine plus oxaliplatin compared with fluorouracil/leucovorin plus oxaliplatin in the treatment of advanced gastric cancer |
Page:— |
| 135. Clinical study of video-assisted mini-thoractomy surgery for lung tumor with lymphadenectomy |
Page:— |
| 136. Loop electrosurgical excision procedure for treatment of CINⅢ and cervical carcinoma stage Ⅰ_(A1) |
Page:— |
| 137. Whether the hepatitis B virus envelope as a gene transfer vector has targeting ability for liver cancer |
Page:— |
| 138. Expression and clinical signifi cance of Mel-18 mRNA in gastric carcinoma |
Page:— |
| 139. Isolation and identification of small cell lung cancer stem-like cells |
Page:— |
| 140. Relationship between standard uptake value of ~(18)F-FDG PET/CT and overexpression of glucose transporter-1 and proliferating cell nuclear antigen in nasopharyngeal carcinoma |
Page:— |
| 141. Analysis of clinicopathologic features and prognosis-related factors in triple-negative breast cancer |
Page:— |
| 142. Value of different biological markers in prediction of response to neoadjuvant chemotherapy in breast cancer |
Page:— |
| 143. Expression and clinical pathological significance of E-cadherin and ?-catenin in esophageal squamous cell carcinoma |
Page:— |
| 144. The effect and mechanism of murine serum amyloid A 1,2,3,4 on metastasis of Lewis lung carcinoma cell lines |
Page:— |
| 145. EML4-ALK fusion oncogene and non-small cell lung cancer |
Page:— |
| 146. Relations between human papilloma virus infection and head and neck cancers |
Page:— |
| 147. Advances of research on realted gene of gastric carcinoma |
Page:— |
| 148. Angiogenesis research and its progresses in the field of hepatocellular carcinoma |
Page:— |
| 149. Combining chemotherapy and TCM recipe “Xiao Zheng Fang” for advanced colorectal cancer |
Page:— |
| 150. The correlation between hEST2 reverse transcription motif and the activity of telomerase |
Page:— |
| 151. Ifosfamine and etoposide in 26 cases with relapse ovarian carcinoma |
Page:— |
| 152. Value of ~(99m)Tc MIBI scintimammography in the differential diagnosis betwwen benign breast tumor,breast cancer and lymph node involvement |
Page:— |
| 153. Mitoxantrone,fluorouracil and leucovorin in the treatment of 41 cases with metastatic breast cancer |
Page:— |
| 154. Effect of exogenous P14ARF gene on the growth of human glioma cells |
Page:— |
| 155. High dose epirubicin containing combination regimen in the treatment of advanced breast cancer |
Page:— |
| 156. The clinical diagnosis of prostatic cancer (report of 161 cases) |
Page:— |
| 157. Treatment of olfactory neuroblastoma with surgery plus irradiation——a report of 14 cases |
Page:— |
| 158. Low dose fluorouracil and cisplatin continuous infusion for the treatment of advanced gastric carcinoma |
Page:— |
| 159. Changes of preoperative and postoperative NK and T lymphocyte with gastric cancer |
Page:— |
| 160. A comparison of the effects of three chemotherapy regimens for advanced non small cell lung cancer |
Page:— |
| 161. The role of CK7 monoclonal antibodies in indentification of primary and metastatic malignant ascites due to ovarian carcinoma |
Page:— |
| 162. Differential diagnosis between the proliferative Kikuchi lymphadenitis and malignant lymphoma |
Page:— |
| 163. Comparative study on P53 mRNA in colorectal tumor paraffin embedded samples by RT PCRIS |
Page:— |
| 164. The role of interleukin 6 and interleukin 6 receptor in gliomas |
Page:— |
| 165. The role of dendritic cells mediated antitumor immunity in esophageal carcinoma |
Page:— |
| 166. Etiological role of Val384Asp in hMLH1 gene in gastric and esophageal cancers |
Page:— |
| 167. Sentinel lymph node biopsy in breast cancer using radiolabeled sulphur colloid |
Page:— |
| 168. Outcome and reproductive function after conservative surgery for borderline ovarian tumors |
Page:— |
| 169. Changes in the lymphocyte subgroup after TACE, THPP of primary hepatic carcinoma |
Page:— |
| 170. Radiation-induced fibrosis in rat lung: Modification by hydroxypiperquin phosphate |
Page:— |
| 171. Expression of chemokine receptor CXCR4 in hypopharyngeal carcinoma and its significance |
Page:— |
| 172. Advance in the study on the clinical characteristics,diagnosis and therapy for primary lung cancer in young patients |
Page:— |
| 173. Advance on stereotactic radiotherapy for early stage non-small cell lung cancer |
Page:— |
| 174. Clinical efficacy of surgical therapy in patients with advanced gastric cancer after pre-operative neoajnvant chemotherapy |
Page:— |
| 175. Efficacy of neoadjuvant chemotherapy with antracyclines plus paclitaxel or docetaxel regimen in stageⅢbreast cancer patients |
Page:— |
| 176. Clinical analysis of treatment outcome for 559 patients with endometrial cancer |
Page:— |
| 177. Clinicopathologic features,surgical methods and prognosis in peripheral<2 cm(of diameter) non-small cell lung cancer |
Page:— |
| 178. A randomized controlled study of Shenfu injection combined vinorelbine chemotherapy on the quality of life of elderly non-small cell lung cancer patients |
Page:— |
| 179. Efficacy of calf spleen extraction injection combined chemotherapy in the treatment of advanced nonsmall cell lung cancer |
Page:— |
| 180. Chromosomal analysis of lung cancer by comparative genomic hybridization |
Page:— |
| 181. Expressions of MG7 in tissue and serum in cancerization risk prediction of gastric precancerosis and its clinical significance |
Page:— |
| 182. NK/T cell infiltration and prognosis in primary squamous cell carcinoma of the lung |
Page:— |
| 183. Promotion of invasion and metastasis in human breast carcinoma MCF-7 by SDF-1? |
Page:— |
| 184. Expression and correlation of p27 and survivin in NSCLC |
Page:— |
| 185. Expression of tyrosine kinase receptor B in OVCAR-3 ovarian cancer cells and its significance |
Page:— |
| 186. The role of GSK-3?in apoptosis induced by proteasome inhibitors combined with paclitaxel in ovarian cancer cells and its possible mechanism |
Page:— |
| 187. An oncosis-like cell death of pancreatic cancer Panc-1 cells induced by artesunate is related to generation of reactive oxygen species |
Page:— |
